Breast cancer, the world’s most commonly diagnosed cancer, is a heterogeneous disease that demands appropriate diagnosis for better patient management. Thus, the understanding of the molecular mechanisms of tumor heterogeneity, as well as the characteri
NCCN Guideline update: Breast Cancer Version 1.2004. National Comprehensive Cancer N. NCCN guideline update: breast cancer version 1.2004. J Natl Compr Cancer Netw JNCCN. 2004;2 (3):183-4.National Comprehensive Cancer Network. Clinical prac- tice guidelines in oncology: breast cancer -... NCC...
乳腺癌(Breast cancer)(下) 5 治疗 5.1 方法注意事项 手术被认为是早期乳腺癌的主要治疗方法;许多患者通过单纯手术治愈。乳腺癌手术的目的包括完整切除原发肿瘤、切缘阴性以降低局部复发的风险、肿瘤及腋窝淋巴结(ALNs)病理分期以提供必要的预后信息。乳腺癌辅助治疗用于治疗微转移病灶(如逃出乳腺和区域淋巴结但还没有...
1. Guideline principles 2. Principles for disease assessment of advanced breast cancer 3. Principles for ABC treatment 4. Treatment of unresectable locally advanced breast cancer 5. General principles of chemotherapy for ABC 6. Treatment for HR+ and HER2- ABC 7. Treatment for HER2-positive ABC ...
NCCN Updates Guidelines on Breast Cancer TreatmentChristin Melton
stage I/II breast cancer who have clinically negative axilla, "sentinel lymph node biopsy [SLNB] is now the standard of care" in staging these nodes, said Robert Carlson, MD, during the breast cancer guideline update here at the National Comprehensive Cancer Network (NCCN) 15th Annual ...
Management of the axilla in early-stage breast cancer: Ontario Health (Cancer Care Ontario) and ASCO guideline. J Clin Oncol. 2021;39(27):3056-3082. doi:10.1200/JCO.21.00934 PubMedGoogle ScholarCrossref 7. Gradishar WJ, Moran MS, Abraham J, et al. NCCN guidelines:...
[5] G Curigliano, L Castelo-Branco, A Gennari, et al. ESMO Metastatic Breast Cancer Living Guideline. Ann Oncol 2021;32(12): 1475-1495, ESMO Metastatic Breast Cancer Living Guidelines, v1.1 May 2023. 王坤 教授 广东省人民医院肿瘤医院副院长、博士研究生导师 ...
NCCN guidelines updates: breast cancer J Natl Compr Canc Netw, 16 (2018), pp. 605-610 CrossrefView in ScopusGoogle Scholar 2 L. Biganzoli, L. Marotti, C.D. Hart, et al. Quality indicators in breast cancer care: an update from the EUSOMA working group Eur J Cancer, 86 (2017), ...
These NCCN Guidelines Insights highlight the important updates/changes to the surgical axillary staging, radiation therapy, and systemic therapy recommendations for hormone receptor-positive disease in the 1.2017 version of the NCCN Guidelines for Breast Cancer. This report summarizes these updates and dis...